MDxHealth S.A.
MDXH
Clasificación en acciones
#21631
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Precio por acción
$3.39
Última sincronización: 2023-12-15
Capitalización bursátil
$96.16M
Cambio (1 día)
-1.73%
Cambio (1 año)
-1.41%
País
BE
Comercio MDxHealth S.A. (MDXH)
Categoría
Healthcare
Historial del precio de la acción de MDxHealth S.A. (MDXH)
Precio más alto de cierre: $3.26 el 2023-12-01
Precio más bajo de cierre: $609.22 el 2014-04-01
Precio más bajo de cierre: $609.22 el 2014-04-01
Historial del precio de la acción de MDxHealth S.A. desde 2014 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2023 | -94.81% |
| 2022 | -41.40% |
| 2021 | 0.43% |
| 2020 | -0.13% |
| 2019 | -49.53% |
| 2018 | -51.17% |
| 2017 | -13.55% |
| 2016 | 21.39% |
| 2015 | -23.63% |
| 2014 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $685.62 | 20.88% |
US
|
|
| $233.67 | 7.14% |
US
|
|
| $412.14 | 119.20% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $175.87 | 20.57% |
US
|
